Search for a clinical trial
Other search option(s)
7 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Terminated trial = 
; Funded by an IRDiRC member = 
; Study involving ERN members in at least two Member States = 
National clinical trial(s)
AUSTRIA
TIROL
INNSBRUCK
A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport® and Dysport RU®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RU® Following Repeated Treatments of Subjects With Cervical Dystonia - AT
Medizinische Universität Innsbruck
Universitätsklinik für Neurologie
BELGIUM
ANTWERPEN
EDEGEM (ANTWERPEN)
A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport® and Dysport RU®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RU® Following Repeated Treatments of Subjects With Cervical Dystonia- BE (completed)
Antwerp University Hospital - UZA
Dienst neurologie/Department of Neurology - UZA
FRANCE
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport® and Dysport RU®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RU® Following Repeated Treatments of Subjects With Cervical Dystonia - FR
Institution: Information not provided - FR
FRANCE
OCCITANIE
TOULOUSE
EBTox : Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study (Phase II-III)
CHU de Toulouse - Hôpital Larrey
Centre de référence des maladies rares de la peau
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport® and Dysport RU®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RU® Following Repeated Treatments of Subjects With Cervical Dystonia -DE-
Institution: Information not provided - DE
ITALY
UMBRIA
PERUGIA
Botulinum A Toxin Intravesical Injections Versus Bladder Overdistension in the Treatment of Patients With Painful Bladder Syndrome: A Prospective Randomized Study
Azienda Ospedaliera Universitaria di Perugia Santa Maria della Misericordia
Clinica Urologica
NETHERLANDS
Utrecht
ADDRESS: NOT PROVIDED - NL